Want to join the conversation?
Pre-clinical and clinical laboratory services provider $CRL agreed to acquire WIL Research for approx. $585MM in cash, subject to customary closing adjustments. The transaction is scheduled to close early in 2Q16. Based on the anticipated timing of the close, the acquisition is expected to add $150-170MM to $CRL's 2016 consolidated revenue.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)